Including DM CLEAR!
A lot of the tests with Wisdom Panel target other
breeds and do not technically pose a risk to the German Shepherd.
However, I will list below the ones that could pose a risk.
More tests than are listed below were tested for, and all were CLEAR on the full panel for Beau!
-----------------------------------------
Acral Mutilation Syndrome
Acute Respiratory Distress Syndrome
Alexander Disease
Bandera’s Neonatal Ataxia
Benign Familial Juvenile Epilepsy
Canine Leukocyte Adhesion Deficiency aka (CLAD) Type III
Canine Multifocal Retinopathy 1, 2 and 3
Canine Scott Syndrome
Cerebellar Ataxia
Cerebellar Cortical Degeneration
Cerebellar Hypoplasia
Cerebral Dysfunction
Cleft Lip & Palate (Also CL&P with Syndactyly)
Complement 3 Deficiency
Cone Degeneration
Cone-Rod Dystrophy
Congenital Stationary Night Blindness aka (CSNB)
Cystic Renal Dysplasia and Hepatic Fibrosis
Cystinuria Type I-A & II-A
(DM) aka Degenerative Myelopathy
Dental Hypomineralization
Dominant Progressive Retinal Atrophy (DPRA)
Epidermolytic Hyperkeratosis
Episodic Falling Syndrome (EFS)
Exercise-Induced Collapse (EIC)
Factor VII, XI Syndrome
Fanconi Syndrome
Fetal Onset Neuroaxonal Dystrophy
Focal Non-Epidermolytic Palmoplantar Keratoderma
Glycogen Storage Disease Type IIIa (GSD IIIa)
Hemophilia A – Variant’s 1 & (2-German Shepherd Dog)
Hemophilia B
Hereditary Elliptocytosis
Hereditary Footpad Hyperkeratosis (HFH)
Hereditary Vitamin D-Resistant Rickets Type II (HVDRR)
Hyperuricosuria (HUU)
Hypocatalasia
Hypomyelination
Hypophosphatasia
Juvenile Laryngeal Paralysis and Polyneuropathy (JLPP)
Juvenile Myoclonic Epilepsy
Lagotto Storage Disease
Lamellar Ichthyosis
Ligneous Membranitis
MDR1 Medication Sensitivity (MDR1)
May-Hegglin Anomaly
Mucopolysaccharidosis Type VII (Discovered in the German Shepherd Dog)
Muscular Hypertrophy (Double Muscling)
Musladin-Lueke Syndrome
Myeloperoxidase Deficiency
Myotubular Myopathy
Nemaline Myopathy
Neonatal Cerebellar Cortical Degeneration
Neonatal Encephalopathy with Seizures
Neuronal Ceroid Lipofuscinosis 1 (NCL1)
Neuronal Ceroid Lipofuscinosis 7 (NCL7)
Obesity Risk (Pomc)
Osteochondrodysplasia
P2RY12- Associated Bleeding Disorder
Paroxysmal Dyskinesia
Persistent Mullerian Duct Syndrome (PMDS)
Phosphofructokinase Deficiency (PKF)
Polycystic Kidney Disease (PKD)
Primary Ciliary Dyskinesia
Primary Lens Luxation
Progressive Early-Onset Cerebellar Ataxia
Progressive Retinal Atrophy III, and 1 (PRA)
Progressive Rod Cone Degeneration (prcd-pra)
Protein Losing Nephropathy
Pyruvate Dehydrogenase Phosphatase 1 Deficiency (PDP1)
QT Syndrome (LQTS)
Renal Cystadenocarcinoma and Nodular Dermatofibrosis
Rode-Cone Dysplasia (1, 1a & 3)
Sensory Ataxic Neuropathy (SAN)
Sensory Neuropathy
Skeletal Dysplasia 2
Spinocerebellar Ataxia (Late onset Ataxia) (LOA)
Spinocerebellar Ataxia with Myokymia and / or Seizures (SAMS)
Spondylocostal Dysostosis
Spongy Degeneration with Cerebellar Ataxia (SDCA1) (SDCA2)
Trapped Neutrophil Syndrome
X-Linked Ectodermal Dysplasia
X-Linked Myotubular Myopathy (XLMTM)
X-Linked Progressive Retinal Atrophy 1 & 2 (XLPRA1) (XLPRA2)
X-Linked Tremors
Von Willebrand’s Disease (Type 1,2 and 3) (vWD)